Roche Holding AG (RHHBF OTCQX) stock market data APIs
$341.0593
2.1(0.6%)
as of November 7, 2025
Try our APIs with
free plan!
Roche Holding AG Financial Data Overview
Price chart is built with
Anychart
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.
Prev. Close
341.0593
Open
343.1589
High
351.1895
Low
339.0805
52 wk Range
272.0136-395.28
Market Cap
262 143 M
P/E Ratio
23.4483
Shares Outstanding
107 M
Revenue
63 488 M
EPS
4.8905
Dividends (Yield)
0.0285
Beta
0.169
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Roche Holding AG (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Roche Holding AG data using free add-ons & libraries
Get Roche Holding AG Fundamental Data
Roche Holding AG Fundamental data includes:
- Net Revenue: 63 488 M
- EBITDA: 23 429 M
- Earnings Per Share: 14
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-04-21
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Roche Holding AG News
New
Prothena Q3 Earnings Miss Estimates, Pipeline Progress in Focus
Prothena Corporation PRTA reported third-quarter 2025 adjusted loss per share (excluding restructuring costs) of 67 cents, much wider than the Zacks Consensus Estimate of a loss of 60 cents. In the ye...
U.S. launches pilot payment model to bring MFN pricing to Medicaid
[Medicaid newspaper headline on hundred dollar bills with US Capitol in Washington DC] The U.S. has introduced a new pilot program to allow State and federally backed Medicaid healthcare programs to ...
Prothena Reports Third Quarter 2025 Financial Results and Business Highlights
Net cash used in operating and investing activities was $40.6 million and $140.4 million for the third quarter and first nine months of 2025, respectively; quarter-end cash and restricted cash positio...
EXEL Tops Q3 Earnings Estimates, Cabometyx Fuels Product Sales
Exelixis, Inc. EXEL reported better-than-expected results for the third quarter of 2025. Adjusted earnings of 78 cents per share beat the Zacks Consensus Estimate of 68 cents. The company registered ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
